Literature DB >> 7477835

99mTc HM-PAO brain perfusion SPECT in brain death.

M G Bonetti1, P Ciritella, G Valle, E Perrone.   

Abstract

Diagnosis of brain death must be certain to allow discontinuation of artificial ventilation and organ transplantation. Brain death is present when all functions of the brain stem have irreversibly ceased. Clinical and electrophysiological criteria may be misinterpreted due to drug intoxication, hypothermia or technical artefacts. Thus, if clinical assessment is suboptimal, reliable early confirmatory tests may be required for demonstrating absence of intracranial blood flow. We have easily carried out and interpreted 99mTc HM-PAO SPECT in a consecutive series of 40 comatose patients with brain damage, without discontinuing therapy. Brain death was diagnosed in 7 patients, by recognising absence of brain perfusion, as shown by no intracranial radionuclide uptake. In patients in whom perfusion was seen on brain scans, HM-PAO SPECT improved assessment of the extent of injury, which in general was larger than suggested by CT.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7477835     DOI: 10.1007/bf00588013

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  10 in total

1.  Intravenous digital subtraction angiography. A criteria of brain death.

Authors:  Y Van Bunnen; C Delcour; D Wery; B Richoz; J Struyven
Journal:  Ann Radiol (Paris)       Date:  1989

2.  MR diagnosis of brain death.

Authors:  K M Jones; P D Barnes
Journal:  AJNR Am J Neuroradiol       Date:  1992 Jan-Feb       Impact factor: 3.825

Review 3.  Brain death (first of two parts).

Authors:  P M Black
Journal:  N Engl J Med       Date:  1978-08-17       Impact factor: 91.245

4.  Assessment of coma and impaired consciousness. A practical scale.

Authors:  G Teasdale; B Jennett
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

5.  A simplified acute physiology score for ICU patients.

Authors:  J R Le Gall; P Loirat; A Alperovitch; P Glaser; C Granthil; D Mathieu; P Mercier; R Thomas; D Villers
Journal:  Crit Care Med       Date:  1984-11       Impact factor: 7.598

6.  Guidelines for the determination of death. Report of the medical consultants on the diagnosis of death to the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research.

Authors: 
Journal:  JAMA       Date:  1981-11-13       Impact factor: 56.272

7.  Tc-99m HMPAO cerebral scintigraphy. A reliable, noninvasive method for determination of brain death.

Authors:  H Wieler; K Marohl; K P Kaiser; P Klawki; H Frössler
Journal:  Clin Nucl Med       Date:  1993-02       Impact factor: 7.794

8.  Clinical use of technetium-99m HM-PAO for determination of brain death.

Authors:  R H Reid; K Y Gulenchyn; J R Ballinger
Journal:  J Nucl Med       Date:  1989-10       Impact factor: 10.057

9.  Cerebral perfusion imaging with technetium-99m HM-PAO in brain death and severe central nervous system injury.

Authors:  N R Laurin; A A Driedger; G A Hurwitz; A G Mattar; J E Powe; M J Chamberlain; P L Zabel; W F Pavlosky
Journal:  J Nucl Med       Date:  1989-10       Impact factor: 10.057

  10 in total
  9 in total

Review 1.  A critique of ancillary tests for brain death.

Authors:  G Bryan Young; Donald Lee
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Severe brain injury to neurological determination of death: Canadian forum recommendations.

Authors:  Sam D Shemie; Christopher Doig; Bernard Dickens; Paul Byrne; Brian Wheelock; Graeme Rocker; Andrew Baker; T Peter Seland; Cameron Guest; Dan Cass; Rosella Jefferson; Kimberly Young; Jeanne Teitelbaum
Journal:  CMAJ       Date:  2006-03-14       Impact factor: 8.262

3.  Tc-99m-HMPAO single photon emission computed tomography (SPECT) as an ancillary test in the diagnosis of brain death.

Authors:  U Keske
Journal:  Intensive Care Med       Date:  1998-09       Impact factor: 17.440

4.  Clinical utility of arterial spin-labeling as a confirmatory test for suspected brain death.

Authors:  K M Kang; T J Yun; B-W Yoon; B S Jeon; S H Choi; J-H Kim; J E Kim; C-H Sohn; M H Han
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-08       Impact factor: 3.825

Review 5.  Nuclear medicine and the emergency department patient: an illustrative case-based approach.

Authors:  Fatemeh Behnia; Joel A Gross; Monica Ragucci; Serena Monti; Marcello Mancini; Shana Elman; Hubert Vesselle; Lorenzo Mannelli
Journal:  Radiol Med       Date:  2014-08-13       Impact factor: 3.469

6.  "Any possible restoration of function could not occur": Harvey Cushing and the early description of brain death.

Authors:  Courtney Pendleton; Bowen Jiang; Romergryko G Geocadin; Alfredo Quinones-Hinojosa
Journal:  World Neurosurg       Date:  2011-11-07       Impact factor: 2.104

Review 7.  [Current concepts in diagnosing brain death in Germany].

Authors:  F Thömke; L S Weilemann
Journal:  Med Klin (Munich)       Date:  2000-02-15

8.  99mTc-HMPAO SPECT in the diagnosis of brain death.

Authors:  E Facco; P Zucchetta; M Munari; F Baratto; A U Behr; M Gregianin; A Gerunda; F Bui; M Saladini; G Giron
Journal:  Intensive Care Med       Date:  1998-09       Impact factor: 17.440

9.  Outcomes of patients referred for confirmation of brain death by 99mTc-exametazime scintigraphy.

Authors:  James W Harding; Barry E Chatterton
Journal:  Intensive Care Med       Date:  2003-03-25       Impact factor: 17.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.